Latest Security News

Askari Metals has acquired 100% ownership of Rift Valley Metals, gaining a highly prospective 460 km² gold project portfolio in Ethiopia’s underexplored Adola Greenstone Belt. This move positions the company at the forefront of exploration in a prolific gold region with significant discovery potential.

Little Green Pharma reported a robust 40% revenue increase for FY25, driven by strong European sales and the strategic acquisition of Health House. The company also advanced clinical research and secured new therapy funding, positioning itself for continued growth.

Boab Metals has inked a A$10 million deal to acquire the DeGrussa Processing Plant from Sandfire Resources, significantly derisking and reducing upfront capital costs for its Sorby Hills Project. Completion hinges on a final investment decision expected in the second half of 2025.

Perpetual Resources has raised $500,000 through a strongly supported placement to fund its maiden lithium drilling campaign at the Igrejinha Project in Brazil, following high-grade assay results that have boosted investor confidence.

Tissue Repair Limited reports progress in its Phase 3 clinical trials for TR987® despite enrollment delays caused by US regulatory disruptions, while TR Pro+® sales hit record highs and manufacturing scale-up advances.

Perpetual Resources has completed a transformational acquisition of three lithium projects in Brazil’s Lithium Valley, confirming high-grade spodumene mineralisation and advancing drilling plans for Q2 2025. Metallurgical tests at its Raptor Rare Earth Project show strong recoveries of critical magnet rare earth elements.

Omni Bridgeway reports robust investment performance for FY25, highlighted by record proceeds and a landmark Fund 9 transaction that strengthens its balance sheet and strategic position.

Pure Hydrogen Corporation has marked significant progress in its clean energy transition, delivering Australia's first hydrogen fuel cell garbage truck and securing multi-million dollar contracts with industry leaders TOLL Transport and Heidelberg Materials.

Argent BioPharma reports significant operational savings through manufacturing outsourcing, encouraging Phase IIb results for CimetrA®, and key regulatory approvals for cannabinoid therapies in Germany.

Australian Rare Earths Limited (ASX: AR3) has successfully raised $3.6 million through a fully subscribed rights issue, backed strongly by existing shareholders and directors. The capital injection positions AR3 to advance uranium exploration and rare earth development amid favorable geopolitical shifts.

Horizon Oil reported steady Q3 FY25 production and cash flow, paid its fifth consecutive interim dividend, and announced a strategic acquisition in Thailand that promises to boost production and diversify its asset base.

QMines Limited reports a 42% increase in Indicated resources at Develin Creek following maiden drilling, completes a $4 million capital raise, and moves to acquire the Mount Mackenzie gold-silver project, signaling a strategic expansion in Queensland.